IceCure Receives Additional FDA Clearance For Its Cancer Freezing Technology

Image caption:  A rendering of IceCure’s technology. Photo: IceCure Medical Ltd.

Tel Aviv-listed medtech company IceCure Medical Ltd. has been cleared by the U.S. Food and Drug Administration (FDA) to use its tumor-freezing technology on additional types of cancers, IceCure announced Tuesday.

The company was already cleared to use its technology on breast cancer patients. Following the new FDA clearance, the company can market its technology in the U.S. for the treatment of cancerous and benign tumors of the kidney, liver, ear, nose, and throat. […]

Click here to view original web page at www.calcalistech.com